G. Solbu

4.6k total citations
51 papers, 2.1k citations indexed

About

G. Solbu is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, G. Solbu has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 27 papers in Public Health, Environmental and Occupational Health and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in G. Solbu's work include Acute Myeloid Leukemia Research (29 papers), Acute Lymphoblastic Leukemia research (27 papers) and Childhood Cancer Survivors' Quality of Life (12 papers). G. Solbu is often cited by papers focused on Acute Myeloid Leukemia Research (29 papers), Acute Lymphoblastic Leukemia research (27 papers) and Childhood Cancer Survivors' Quality of Life (12 papers). G. Solbu collaborates with scholars based in Netherlands, Belgium and France. G. Solbu's co-authors include Stefan Suciu, R Zittoun, Bob Löwenberg, M. Peetermans, Pieter Sonneveld, H M Lokhorst, U. Jehn, J. Abels, C Cauchie and L Debusscher and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

G. Solbu

51 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Solbu Netherlands 21 1.3k 779 707 613 382 51 2.1k
G. Henze Germany 22 673 0.5× 1.1k 1.4× 436 0.6× 350 0.6× 182 0.5× 50 1.7k
Birgitte Lausen Denmark 23 1000 0.8× 790 1.0× 426 0.6× 388 0.6× 261 0.7× 84 1.7k
Thomas S. McConnell United States 15 897 0.7× 371 0.5× 631 0.9× 646 1.1× 200 0.5× 26 1.6k
Jean‐Pierre Jouet France 17 1.5k 1.2× 379 0.5× 443 0.6× 286 0.5× 340 0.9× 39 1.9k
G. L. Phillips Canada 20 931 0.7× 366 0.5× 507 0.7× 265 0.4× 325 0.9× 47 1.6k
M Zimmermann Germany 29 2.3k 1.7× 2.3k 3.0× 634 0.9× 802 1.3× 348 0.9× 61 3.7k
Susan McKenzie United States 14 766 0.6× 439 0.6× 342 0.5× 367 0.6× 247 0.6× 19 1.2k
Catherine Payen France 16 2.4k 1.9× 386 0.5× 1.2k 1.7× 1.4k 2.3× 325 0.9× 25 3.0k
Richard Champlin United States 19 1.1k 0.8× 428 0.5× 638 0.9× 332 0.5× 191 0.5× 52 1.7k
L Resegotti Italy 23 807 0.6× 355 0.5× 624 0.9× 291 0.5× 622 1.6× 93 1.8k

Countries citing papers authored by G. Solbu

Since Specialization
Citations

This map shows the geographic impact of G. Solbu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Solbu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Solbu more than expected).

Fields of papers citing papers by G. Solbu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Solbu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Solbu. The network helps show where G. Solbu may publish in the future.

Co-authorship network of co-authors of G. Solbu

This figure shows the co-authorship network connecting the top 25 collaborators of G. Solbu. A scholar is included among the top collaborators of G. Solbu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Solbu. G. Solbu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Libura, Marta, Anh-Hue Thi Tu, Isabelle Tigaud, et al.. (2002). Flt3 and MLL internal tandem duplications and topoisomerase II breakages reflect a common category of genotoxic stress: An EORTC study. Blood. 100(11). 2 indexed citations
3.
Suciu, Stefan, T de Witte, Franco Mandelli, et al.. (2002). Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial. Bone Marrow Transplantation. 29. 2 indexed citations
4.
Witte, T. de, R Zittoun, L Resegotti, et al.. (2000). The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial.. Blood. 96(11). 5 indexed citations
5.
Ho, Anthony D., Stefan Suciu, Pierre Stryckmans, et al.. (1999). Pentostatin in T-cell malignancies – a phase II trial of the EORTC. Annals of Oncology. 10(12). 1493–1498. 31 indexed citations
6.
7.
8.
9.
Zittoun, R, Stefan Suciu, G. Solbu, et al.. (1995). Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study. Blood. 86(10). 1718–1718. 1 indexed citations
10.
Ferster, Alina, Yves Bertrand, Yves Benoît, et al.. (1994). Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group. British Journal of Haematology. 86(2). 284–290. 53 indexed citations
11.
Willemze, R., Stefan Suciu, Franco Mandelli, et al.. (1994). Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative Group.. PubMed. 8 Suppl 2. S48–55. 5 indexed citations
12.
Falkenrodt, A., Anne‐Marie Manel, Stefan Suciu, et al.. (1994). Immunological Results of Protocol 58881 from EORTC Children Leukemia Cooperative Group. Leukemia & lymphoma. 13(sup1). 99–100. 1 indexed citations
13.
Marcus, R. E., Alain Delmer, H. Zwierzina, et al.. (1994). A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group.. PubMed. 8(1). 16–23. 40 indexed citations
14.
Sonneveld, Pieter, Bob Löwenberg, B G M Durie, et al.. (1992). Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Lancet. 340(8814). 255–259. 273 indexed citations
15.
Veerman, A., K. Hählen, W. A. Kamps, et al.. (1990). Dutch Childhood Leukemia Study Group: Early Results of Study ALL VI (1984–1988). Hämatologie und Bluttransfusion. 33. 473–477. 27 indexed citations
16.
Berg, A van der Does-van den, Elisabeth R. van Wering, Stefan Suciu, et al.. (1988). [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].. PubMed. 56(2). 61–6. 1 indexed citations
17.
Jehn, U., Stefan Suciu, Maham Hayat, et al.. (1988). Testing a predictive regression model for response in adult acute myeloid leukemia comparing two induction regimens of the E.O.R.T.C. -AML-5 and AML-6 trial.. PubMed. 7(6). 1239–43. 2 indexed citations
18.
Stryckmans, Pierre, Théo de Witte, Nizar Bitar, et al.. (1987). Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.. PubMed. 14(2 Suppl 1). 67–72. 14 indexed citations
19.
Berg, Andrej, Elisabeth R. van Wering, J. de Koning, et al.. (1986). Addition of rubidomycine to induction treatment with vincristine, prednison and L-asparaginase in standard risk childhood acute lymphocytic leukemia. Leukemia Research. 10(1). 112–112. 1 indexed citations
20.
Zittoun, R, M Cadiou, C Bayle, et al.. (1984). Prognostic value of cytologic parameters in acute myelogenous leukemia. Cancer. 53(7). 1526–1532. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Henze Breakdown of academic impact, for papers by Birgitte Lausen Breakdown of academic impact, for papers by Thomas S. McConnell Breakdown of academic impact, for papers by Jean‐Pierre Jouet Breakdown of academic impact, for papers by G. L. Phillips Breakdown of academic impact, for papers by M Zimmermann Breakdown of academic impact, for papers by Susan McKenzie Breakdown of academic impact, for papers by Catherine Payen Breakdown of academic impact, for papers by Richard Champlin Breakdown of academic impact, for papers by L Resegotti
Rankless by CCL
2026